Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results
The Power of the Central Laboratory for Immuno-Oncology Drug Development

Sponsors who partner with a global central laboratory should expect optimized outcomes resulting...

Best Practices for Integrating Biomarkers across the Drug Development...

The use of biomarkers throughout all phases of drug development plays an increasingly important...

Strategies for effective neutralizing cell-based assays in early...

Download our white paper to learn about antibody-based immune responses, the role of neutralizing...

Q2 Solutions Central Laboratory Services

Deeper science to drive tailored solutions, optimized quality systems, delivery excellence and...

Comprehensive Sample Management Innovations

Keep track of specimens collected, stored, shipped, tested and reported through innovative...

Delivery Excellence

Optimizing the customer experience through innovative solutions implemented with premium service...

Lab of the Future

How the lab of the future provides scientific, technological, and operational expertise to improve...

Rapid Analysis of Ceftriaxone in Human Intestinal Chyme, Human Plasma, and...

Three novel LC/MS/MS analytical methods for the quantitation of ceftriaxone in various matrices...

Metabolite Profile Comparison Using a HμREL Co-culture Hepatocyte Model...

Determining whether the HμREL model could produce metabolites consistent with those observed in...

Fit for Purpose Development and Validation of a Urea Biomarker Assay to...

Finding a suitable assay for measuring urea levels during human clinical trials

A New Microsampling Hematocrit-Compatible Dried Plasma Card for Fully...

Validation results showing the functional benefit of new book-type DPS cards with good analytical...

From eligibility to CDx: developing and implementing effective biomarker...

Presented at Biomarkers World Congress and Diagnostics on May 18, 2016, this presentation...